Insights › Market reaction

Why Halozyme Therapeutics (HALO) Stock Fell 1.19% in 10 Minutes on Nov 6, 2026

MoveSurge measured one earlier Halozyme Therapeutics headline with an attributed reaction between Aug 8, 2026 and Nov 5, 2026: -6.22% in 10 minutes, on Nov 5, 2026.

Published in ET: Feed time in ET: Company news HALO -1.19% in 10 min after the headline
  • HALO fell 1.19% in the 10 minutes after the 10:05:14 ET headline, from $108.93 to $107.63.
  • 251,541 shares changed hands in those 10 minutes.
  • The first minute was nearly flat at +0.02%; the stock reached -1.19% at 10 minutes.
HALO Why Halozyme Therapeutics (HALO) Stock Fell 1.19% in 10 Minutes on Nov 6, 2026
MoveSurge publish 10:05:14 ET
MoveSurge publish
10:05:14 ET
110.63 108.87 107.06 105.30 105.80 10:03 10:05 10:25
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
HALO 108.93 108.93 108.95 107.63 +0.02% -1.19%

Halozyme Therapeutics (HALO) shares fell 1.19% in the 10 minutes after this headline reached the MoveSurge news feed at 10:05:14 ET on Friday, November 6, 2026: “Halozyme says there is no projected impact on its ability to enter new ENHANZE partnership agreements”

HALO in the first 10 minutes

From a reference price of $108.93 just before the headline, the stock was up 0.02% after one minute and down 1.19%, at $107.63, after 10 minutes. The first minute was nearly flat; the move came after it. 251,541 shares changed hands in those 10 minutes.

Earlier HALO headlines and the measured reaction

MoveSurge measured one earlier Halozyme Therapeutics headline with an attributed reaction between Aug 8, 2026 and Nov 5, 2026: -6.22% in 10 minutes, on Nov 5, 2026.

  1. Nov 5, 2026, 16:06 ET: “Halozyme Therapeutics (HALO) earnings results” (-6.22% in 10 minutes)

Halozyme Therapeutics at a glance

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Market value$14.79 billion (as of Nov 6, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Halozyme Therapeutics stock on November 6, 2026?

At 10:05:14 ET, this headline crossed: “Halozyme says there is no projected impact on its ability to enter new ENHANZE partnership agreements”. The stock fell 1.19% in the next 10 minutes.

How far did HALO move after the headline?

From $108.93 just before the headline to $107.63 10 minutes later, a -1.19% move.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Go live — 7 days for $29 Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.